# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Luke Sergott maintains IQVIA Hldgs (NYSE:IQV) with a Overweight and lowers the price target from $275 to $255.
AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners.
Goldman Sachs analyst Matthew Sykes initiates coverage on IQVIA Hldgs (NYSE:IQV) with a Buy rating and announces Price Targe...
Evercore ISI Group analyst Elizabeth Anderson maintains IQVIA Hldgs (NYSE:IQV) with a Outperform and lowers the price target...